About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Ongoing studies

Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
- N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
- Zanubrutinib
Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction

Not recruiting

2 1
Investigated diseases:
- Pulmonary hypertension
Investigated drugs:
- TX000045
+3
Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Datopotamab Deruxtecan
- Docetaxel
+1
Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Not recruiting

1 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

Not recruiting

3 1
Investigated drugs:
- Sodium Iodide
+3
Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer metastatic
- Non-small cell lung cancer
+7
Study Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1 1
Investigated diseases:
- Non-small cell lung cancer metastatic
Investigated drugs:
- Pembrolizumab
Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Not recruiting

2 1
Investigated drugs:
- Ab-1002
+3
Study on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal

Not recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Osimertinib
Study of Cemiplimab and Chemotherapy Combination for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:

#1 Clinical Trials Search in Europe

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie Ul. Dr. Kazimierza Jaczewskiego 8, Lublin, 20-090, Poland

About Specializations

Medical Center localisation

Ongoing studies

Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Study Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer

Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

Study on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal

Study of Cemiplimab and Chemotherapy Combination for Patients with Advanced Non-Small Cell Lung Cancer

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie Ul. Dr. Kazimierza Jaczewskiego 8, Lublin, 20-090, Poland

About Specializations

Medical Center localisation

Ongoing studies

We use cookies